Excludes commercial-in-confidence projects.
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included.
Open access indicates that an output is open access.
Shanmuganathan, N, Wadham, C, Shahrin, NH, Feng, J, Thomson, D, Wang, P, Kok, CH, King, RM, Kenyon, RR, Lin, M, Ross, DM, Yeung, DT, Scott, HS, Schreiber, AW & Branford, S and 9 other authors 2023, 'Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention', Haematologica: The Hematology Journal, vol. 108, no. 9, pp. 2380-2395.
Open access 1
Shahrin, NH, Wadham, C & Branford, S 2022, 'Defining higher-risk chronic myeloid leukemia: risk scores, genomic landscape, and prognostication', Current Hematologic Malignancy Reports, vol. 17, no. 6, pp. 171-180.
Open access 2 1
Shanmuganathan, N, Wadham, C, Thomson, D, Shahrin, NH, Vignaud, C, Obourn, V, Chaturvedi, S, Yang, F, Feng, J, Saunders, V, Kok, CH, Yeung, D, King, RM, Kenyon, RR, Lin, M, Wang, P, Scott, H, Hughes, T, Schreiber, AW & Branford, S 2022, 'RNA-based targeted gene sequencing improves the diagnostic yield of mutant detection in chronic myeloid leukemia', Journal of Molecular Diagnostics, vol. 24, no. 7, pp. 803-822.
Open access 3
Homan, CC, Venugopal, P, Arts, P, Shahrin, NH, Feurstein, S, Rawlings, L, Lawrence, DM, Andrews, J, King-Smith, SL, Harvey, NL, Brown, AL, Scott, HS & Hahn, CN 2021, 'GATA2 deficiency syndrome: a decade of discovery', Human Mutation, vol. 42, no. 11, pp. 1399-1421.
Open access 11 10 11
Thomson, DW, Shahrin, NH, Wang, PP, Wadham, C, Shanmuganathan, N, Scott, HS, Dinger, ME, Hughes, TP, Schreiber, AW & Branford, S 2020, 'Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia', Leukemia, vol. 34, no. 8, pp. 2051-2063.
Open access 24 15 1
Branford, S, Wang, P, Yeung, DT, Thomson, D, Wadham, C, Shahrin, NH, Marum, JE, Nataren, N, Parker, WT, Shanmuganathan, N, Donaldson, Z, Altamura, H, Georgievski, J, Brown, A, Hahn, C, White, DL, Scott, HS, Schreiber, AW & Hughes, TP and 18 other authors 2018, 'Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease', Blood, vol. 132, no. 9, pp. 948-961.
Open access 118 110 9
Dawar, S, Shahrin, NH, Sladojevic, N, D'Andrea, R, Dorstyn, L, Hiwase, DK & Kumar, S 2016, 'Impaired haematopoietic stem cell differentiation and enhanced skewing towards myeloid progenitors in aged caspase-2-deficient mice', Cell Death and Disease, vol. 7, no. e2509, pp.1-9.
Open access 20 21 10
External engagement & recognition
|Novartis Institutes for Biomedical Research||UNITED STATES|
|Novartis Pharmaceuticals||UNITED STATES|
|Royal Adelaide Hospital||AUSTRALIA|
|South Australian Health and Medical Research Institute (SAHMRI)||AUSTRALIA|
|University of Adelaide||AUSTRALIA|
|University of Chicago||UNITED STATES|
|University of New South Wales||AUSTRALIA|
|University of South Australia||AUSTRALIA|